Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9375 |
High Similarity |
NPD9133 |
Approved |
0.8931 |
High Similarity |
NPD9628 |
Approved |
0.8881 |
High Similarity |
NPD9183 |
Clinical (unspecified phase) |
0.8872 |
High Similarity |
NPD875 |
Clinical (unspecified phase) |
0.8741 |
High Similarity |
NPD1451 |
Approved |
0.8478 |
Intermediate Similarity |
NPD9627 |
Approved |
0.8244 |
Intermediate Similarity |
NPD300 |
Approved |
0.8095 |
Intermediate Similarity |
NPD2604 |
Approved |
0.8082 |
Intermediate Similarity |
NPD2180 |
Approved |
0.8014 |
Intermediate Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD3697 |
Discontinued |
0.7881 |
Intermediate Similarity |
NPD3130 |
Discontinued |
0.7639 |
Intermediate Similarity |
NPD566 |
Approved |
0.7639 |
Intermediate Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD568 |
Approved |
0.7639 |
Intermediate Similarity |
NPD567 |
Approved |
0.7547 |
Intermediate Similarity |
NPD3108 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD3105 |
Discontinued |
0.7218 |
Intermediate Similarity |
NPD9132 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD5768 |
Phase 2 |
0.7031 |
Intermediate Similarity |
NPD8859 |
Approved |
0.7031 |
Intermediate Similarity |
NPD8862 |
Approved |
0.7031 |
Intermediate Similarity |
NPD8861 |
Approved |
0.6918 |
Remote Similarity |
NPD576 |
Discontinued |
0.6872 |
Remote Similarity |
NPD3497 |
Clinical (unspecified phase) |
0.6711 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6573 |
Remote Similarity |
NPD1388 |
Phase 1 |
0.6573 |
Remote Similarity |
NPD1390 |
Phase 1 |
0.6573 |
Remote Similarity |
NPD1389 |
Clinical (unspecified phase) |
0.6507 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.6463 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.645 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.6382 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6349 |
Remote Similarity |
NPD8261 |
Discontinued |
0.6323 |
Remote Similarity |
NPD582 |
Approved |
0.6263 |
Remote Similarity |
NPD7465 |
Suspended |
0.625 |
Remote Similarity |
NPD1120 |
Approved |
0.625 |
Remote Similarity |
NPD1121 |
Approved |
0.6211 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.617 |
Remote Similarity |
NPD757 |
Phase 3 |
0.6145 |
Remote Similarity |
NPD1335 |
Approved |
0.612 |
Remote Similarity |
NPD8641 |
Approved |
0.6102 |
Remote Similarity |
NPD2137 |
Approved |
0.6102 |
Remote Similarity |
NPD2138 |
Approved |
0.6074 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.6051 |
Remote Similarity |
NPD1430 |
Approved |
0.6051 |
Remote Similarity |
NPD1431 |
Approved |
0.6 |
Remote Similarity |
NPD510 |
Phase 1 |
0.6 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.599 |
Remote Similarity |
NPD8271 |
Discontinued |
0.5987 |
Remote Similarity |
NPD9650 |
Phase 3 |
0.5985 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.5974 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.5961 |
Remote Similarity |
NPD8292 |
Phase 2 |
0.5948 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5946 |
Remote Similarity |
NPD8113 |
Phase 2 |
0.5944 |
Remote Similarity |
NPD7245 |
Approved |
0.5944 |
Remote Similarity |
NPD7246 |
Clinical (unspecified phase) |
0.5933 |
Remote Similarity |
NPD515 |
Phase 1 |
0.5926 |
Remote Similarity |
NPD775 |
Approved |
0.5921 |
Remote Similarity |
NPD9632 |
Phase 3 |
0.592 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.5918 |
Remote Similarity |
NPD7557 |
Clinical (unspecified phase) |
0.5912 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.5912 |
Remote Similarity |
NPD2618 |
Phase 1 |
0.5906 |
Remote Similarity |
NPD9544 |
Approved |
0.5906 |
Remote Similarity |
NPD78 |
Approved |
0.5872 |
Remote Similarity |
NPD1777 |
Approved |
0.5872 |
Remote Similarity |
NPD1776 |
Approved |
0.5864 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.5862 |
Remote Similarity |
NPD1368 |
Approved |
0.5844 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.5828 |
Remote Similarity |
NPD1775 |
Approved |
0.5828 |
Remote Similarity |
NPD1085 |
Approved |
0.5805 |
Remote Similarity |
NPD9582 |
Phase 3 |
0.5782 |
Remote Similarity |
NPD307 |
Approved |
0.5776 |
Remote Similarity |
NPD174 |
Discontinued |
0.5769 |
Remote Similarity |
NPD1308 |
Approved |
0.5769 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.5767 |
Remote Similarity |
NPD1249 |
Clinical (unspecified phase) |
0.5759 |
Remote Similarity |
NPD8629 |
Discontinued |
0.575 |
Remote Similarity |
NPD2253 |
Discontinued |
0.5732 |
Remote Similarity |
NPD252 |
Clinical (unspecified phase) |
0.5729 |
Remote Similarity |
NPD2807 |
Discontinued |
0.5714 |
Remote Similarity |
NPD9360 |
Approved |
0.5714 |
Remote Similarity |
NPD578 |
Discontinued |
0.5714 |
Remote Similarity |
NPD1174 |
Phase 2 |
0.5714 |
Remote Similarity |
NPD9291 |
Approved |
0.5714 |
Remote Similarity |
NPD248 |
Discontinued |
0.5706 |
Remote Similarity |
NPD750 |
Phase 2 |
0.5706 |
Remote Similarity |
NPD276 |
Clinical (unspecified phase) |
0.5705 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.5699 |
Remote Similarity |
NPD459 |
Clinical (unspecified phase) |
0.5694 |
Remote Similarity |
NPD8119 |
Discontinued |
0.5689 |
Remote Similarity |
NPD9605 |
Phase 3 |
0.5687 |
Remote Similarity |
NPD1118 |
Discontinued |
0.5687 |
Remote Similarity |
NPD549 |
Approved |
0.5686 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.5686 |
Remote Similarity |
NPD1354 |
Approved |
0.5686 |
Remote Similarity |
NPD1356 |
Approved |
0.5678 |
Remote Similarity |
NPD4341 |
Clinical (unspecified phase) |
0.5677 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.5677 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.5655 |
Remote Similarity |
NPD1030 |
Approved |
0.5655 |
Remote Similarity |
NPD1027 |
Approved |
0.5655 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.5647 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.5638 |
Remote Similarity |
NPD460 |
Discontinued |
0.5625 |
Remote Similarity |
NPD9412 |
Discontinued |
0.5625 |
Remote Similarity |
NPD6906 |
Clinical (unspecified phase) |
0.5618 |
Remote Similarity |
NPD966 |
Clinical (unspecified phase) |
0.5612 |
Remote Similarity |
NPD7834 |
Approved |
0.5612 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.5611 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.5604 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.5604
|
Remote Similarity |
NPD2523 |
Phase 2 |